SIREN : 447800210
LABORATOIRE AGUETTANT is a French company founded 23 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in LYON (69007), this company of category ETI shows in 2025 a revenue of 247.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 247 684 636 € | 205 585 025 € | 155 907 874 € | 139 505 350 € | 135 919 762 € | 134 475 845 € | 136 341 978 € | 122 559 782 € | 111 950 286 € |
| Net income | 34 357 213 € | 28 020 038 € | 20 940 979 € | 16 857 188 € | 17 001 318 € | 13 501 029 € | 14 777 270 € | 12 998 858 € | 10 519 773 € |
| EBITDA | 45 573 495 € | 33 063 305 € | 28 301 785 € | 26 282 247 € | 27 983 163 € | 25 366 709 € | 26 013 815 € | 24 308 000 € | 16 724 446 € |
| Net margin | 13.9% | 13.6% | 13.4% | 12.1% | 12.5% | 10.0% | 10.8% | 10.6% | 9.4% |
In 2025, LABORATOIRE AGUETTANT achieves revenue of 247.7 M€. Over the period 2017-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +10.4%. Vs 2024, growth of +20% (205.6 M€ -> 247.7 M€). After deducting consumption (92.8 M€), gross margin stands at 154.9 M€, i.e. a rate of 63%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 45.6 M€, representing 18.4% of revenue. Positive scissor effect: EBITDA margin improves by +2.3 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 34.4 M€, i.e. 13.9% of revenue. This profit can be retained or distributed to shareholders.
247 684 636 €
154 887 065 €
45 573 495 €
33 536 321 €
34 357 213 €
18.2%
The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 18.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
31.868%
60.848%
18.622%
1.148
60.3%
In 2025, the debt ratio of LABORATOIRE AGUETTANT (31.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of LABORATOIRE AGUETTANT (60.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2025, the repayment capacity of LABORATOIRE AGUETTANT (1.15) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 332.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 3.8x. Financial charges are adequately covered by operations.
332.415
3.767
In 2025, the liquidity ratio of LABORATOIRE AGUETTANT (332.42) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2025, the interest coverage of LABORATOIRE AGUETTANT (3.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 61 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 59 days. The company must finance 2 days of gap between collections and payments. Inventory turnover is 84 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 120 days of revenue, i.e. 82.6 M€ to permanently finance. Over 2017-2025, WCR increased by +637%, requiring additional financing.
82 615 210 €
61 j
59 j
84 j
120 j
Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 6 854 925€ to 21 069 362€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LABORATOIRE AGUETTANT with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques
The revenue of LABORATOIRE AGUETTANT in 2025 is 247.7 M€.
Yes, LABORATOIRE AGUETTANT generated a net profit of 34.4 M€ in 2025.
The headquarters of LABORATOIRE AGUETTANT is located in LYON (69007), in the department Rhone.
The tax return of LABORATOIRE AGUETTANT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LABORATOIRE AGUETTANT operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.